Mefloquine associated “Psychiatric side effects”:

More Presentations from Dr.Naina Mohamed Pakkir Maideen

ª  Mefloquine hydrochloride is indicated for the treatment of mild to moderate acute malaria caused by mefloquine-susceptible P. falciparum and P. vivax, and prevention of malaria infections by P. falciparum (including chloroquine-resistant P. falciparum) and P. vivax.

ª  FDA is advising the public about strengthened and updated warnings regarding neurologic and psychiatric side effects associated with Mefloquine hydrochloride.

ª  Physicians who continue to prescribe mefloquine must exercise caution.

ª  If a patient develops neurologic or psychiatric symptoms, mefloquine should be stopped, and an alternate medicine (e.g., doxycycline) should be used.